PyroGenesis Canada Say Green Cement Additive Product Got "Impressive Results" in Strength Tests-February 2024-www.financetom.com

PyroGenesis Canada Say Green Cement Additive Product Got "Impressive Results" in Strength Tests

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

PyroGenesis Canada Say Green Cement Additive Product Got "Impressive Results" in Strength Tests

May 2, 2024 6:49 AM

09:29 AM EDT, 05/02/2024 (MT Newswires) -- PyroGenesis Canada ( PYRGF ) on Thursday announced that it has been advised by its client, Progressive Planet, that the latest series of compressive strength tests on its PozPyro green cement additive product reveal "impressive results," posting strength comparisons significantly above the acceptable standard for similar material.

PozPyro enhances the strength of concrete as a replacement for fly ash, which is in diminishing supply.

Previous page： KDP Discusses Strategy, Leadership and Financing for Upcoming Transformational Transactions Next page： Rakovina Therapeutics Presents Poster at Cancer Therapeutics Conf in Boston

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

KDP Discusses Strategy, Leadership and Financing for Upcoming Transformational Transactions

Oct 27, 2025

At Investor Day, outlines conviction in the JDE Peet's acquisition and robust plans to execute integration and separation Announces capital-efficient $7 billion strategic investment co-led by Apollo and KKR to reduce projected net leverage at acquisition close; sets targeted capital structure for each company at separation BURLINGTON, Mass. and FRISCO, Texas, Oct. 27, 2025 /PRNewswire/ -- Today, Keurig Dr Pepper...

Rakovina Therapeutics Presents Poster at Cancer Therapeutics Conf in Boston

Oct 27, 2025

07:20 AM EDT, 10/27/2025 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) Monday said it has presented new data at an international conference on cancer therapeutics (AACR-NCI-EORTC) in Boston. The company's poster presentation highlighted promising results from its AI-driven kt-5000AI drug discovery program for Ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR) inhibitors for cancer therapy. While multiple ATR inhibitors...

Albemarle Announces Sale of a Controlling Stake in Ketjen to KPS Capital Partners

Oct 27, 2025

Albemarle Separately Signs Agreement to Sell its 50% Stake in Eurecat Joint Venture to Axens SA Combined transactions strengthen Albemarle's financial flexibility and drive greater portfolio focus Albemarle expects to receive total pre-tax cash proceeds of approximately $660 million for the sale of a 51% stake in Ketjen Corporation's refining catalyst solutions business and the sale of its 50% stake...

Form 8.3 - United Group PLC

Oct 27, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a):...